Q: Peter and His Wonder Team
Please give your assessment of there Quarterly Report and their future prognosis. Thank you!
Please give your assessment of there Quarterly Report and their future prognosis. Thank you!
5i Research Answer:
EPS of 8c beat estimates of 6.8c; revenue of $121.6M beat estimates of $120.3M. EBITDA of $17M beat estimates by 19%. Revenue slightly decreased year over year but EPS soared from 1c last year. Production is ramping in Europe and the chemicals and oxides division did very well, the best in years. Outlook commentary was positive, with management stressing its ability to meet supply chain gaps caused by restrictions elswhere (i.e. China). The stock has done very well and is now 17X earnings.